{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:18:29Z","timestamp":1791166709257,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/labinvest.2010.186","type":"journal-article","created":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T11:35:59Z","timestamp":1288611359000},"page":"452-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease"],"prefix":"10.1016","volume":"91","author":[{"given":"Luca","family":"Elli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele M","family":"Ciulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Busca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda","family":"Roncoroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Maioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Bardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Bonura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Paliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Terrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Braidotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2010.186_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2010.186_bib2","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.3748\/wjg.v13.i42.5577","article-title":"Innate immunity in inflammatory bowel disease","volume":"13","author":"Yamamoto-Furusho","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1038\/labinvest.2010.186_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3748\/wjg.15.521","article-title":"Do we really understand what the immunological disturbances in inflammatory bowel disease mean?","volume":"15","author":"Tsianos","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"10.1038\/labinvest.2010.186_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000089781","article-title":"Inflammatory bowel disease: current therapeutic options","volume":"73","author":"Domenech","year":"2006","journal-title":"Digestion"},{"key":"10.1038\/labinvest.2010.186_bib5","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1053\/j.gastro.2009.02.001","article-title":"Biological therapies for inflammatory bowel diseases","volume":"136","author":"Rutgeerts","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2010.186_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.dld.2007.07.169","article-title":"Novel therapeutic options in the inflammatory bowel disease world","volume":"40","author":"Noble","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1038\/labinvest.2010.186_bib7","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1074\/jbc.M205812200","article-title":"Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders","volume":"278","author":"Lesort","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2010.186_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharmthera.2007.05.003","article-title":"Transglutaminase 2 inhibitors and their therapeutic role in disease states","volume":"115","author":"Siegel","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"Pt 2","key":"10.1038\/labinvest.2010.186_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj20021234","article-title":"Transglutaminases: nature's biological glues","volume":"368","author":"Griffin","year":"2002","journal-title":"Biochem J"},{"key":"10.1038\/labinvest.2010.186_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.dld.2008.12.095","article-title":"Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver","volume":"41","author":"Elli","year":"2009","journal-title":"Dig Liver Dis"},{"issue":"Suppl 1","key":"10.1038\/labinvest.2010.186_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1471-4159.2009.05843.x","article-title":"Transglutaminases and neurodegeneration","volume":"109","author":"Jeitner","year":"2009","journal-title":"J Neurochem"},{"key":"10.1038\/labinvest.2010.186_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1471-4159.2005.03357.x","article-title":"Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease","volume":"95","author":"Van Raamsdonk","year":"2005","journal-title":"J Neurochem"},{"key":"10.1038\/labinvest.2010.186_bib13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0968-0004(02)02182-5","article-title":"Transglutaminase 2: an enigmatic enzyme with diverse functions","volume":"27","author":"Fesus","year":"2002","journal-title":"Trends Biochem Sci"},{"issue":"Suppl 1","key":"10.1038\/labinvest.2010.186_bib14","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1038\/sj.cdd.4401112","article-title":"Tissue transglutaminase in HCV infection","volume":"10","author":"Nardacci","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1038\/labinvest.2010.186_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-1759(02)00077-7","article-title":"\u2018Tissue' transglutaminase in AIDS","volume":"265","author":"Amendola","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1038\/labinvest.2010.186_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00726-008-0190-y","article-title":"Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications","volume":"36","author":"Collighan","year":"2009","journal-title":"Amino Acids"},{"key":"10.1038\/labinvest.2010.186_bib17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/gut.2004.049411","article-title":"Differential expression of multiple transglutaminases in human colon: impaired keratinocyte transglutaminase expression in ulcerative colitis","volume":"54","author":"D'Argenio","year":"2005","journal-title":"Gut"},{"key":"10.1038\/labinvest.2010.186_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/73-0891693021000005402","article-title":"Factor XIII and tissue transglutaminase antibodies in coeliac and inflammatory bowel disease","volume":"35","author":"Sjober","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1038\/labinvest.2010.186_bib19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.dld.2006.05.003","article-title":"Anti-tissue transglutaminase in inflammatory bowel diseases: an activity disease-related phenomenon?","volume":"38","author":"Tursi","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1038\/labinvest.2010.186_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vascn.2003.12.002","article-title":"Animal models of inflammatory bowel disease","volume":"50","author":"Jurjus","year":"2004","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1038\/labinvest.2010.186_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1012860509440","article-title":"Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut","volume":"25","author":"Kankuri","year":"2001","journal-title":"Inflammation"},{"key":"10.1038\/labinvest.2010.186_bib22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3945\/jn.110.121525","article-title":"Glutamine prevents fibrosis development in rats with colitis induced by 2,4,6-trinitrobenzene sulfonic acid","volume":"140","author":"San-Miguel","year":"2010","journal-title":"J Nutr"},{"key":"10.1038\/labinvest.2010.186_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/08830180009048389","article-title":"TNBS-colitis","volume":"19","author":"Neurath","year":"2000","journal-title":"Int Rev Immunol"},{"key":"10.1038\/labinvest.2010.186_bib24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0016-5085(89)80079-4","article-title":"Hapten-induced model of chronic inflammation and ulceration in the rat colon","volume":"96","author":"Morris","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2010.186_bib25","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1023\/A:1026620322859","article-title":"Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects","volume":"44","author":"Gaudio","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1038\/labinvest.2010.186_bib26","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1478-3231.2008.01749.x","article-title":"Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line","volume":"28","author":"Roncoroni","year":"2008","journal-title":"Liver Int"},{"key":"10.1038\/labinvest.2010.186_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0891-0618(96)00124-X","article-title":"Immunoautoradiographic and in situ hybridization analysis of corticotropin-releasing hormone biosynthesis in the hypothalamic paraventricular nucleus","volume":"11","author":"Herman","year":"1996","journal-title":"J Chem Neuroanat"},{"key":"10.1038\/labinvest.2010.186_bib28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1089\/aid.2009.0091","article-title":"Sulfur metabolism in AIDS: cystamine as an anti-HIV agent","volume":"25","author":"Toohey","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1038\/labinvest.2010.186_bib29","doi-asserted-by":"crossref","first-page":"PL27","DOI":"10.1016\/S0024-3205(97)01066-7","article-title":"S-methylthio-cysteine and cystamine are potent stimulators of thiol production and glutathione synthesis","volume":"62","author":"Jokay","year":"1998","journal-title":"Life Sci"},{"key":"10.1038\/labinvest.2010.186_bib30","first-page":"875","article-title":"Effect of cystamine on rat tissue GSH level and glutathione reductase activity","volume":"155","author":"Kovarova","year":"1979","journal-title":"Strahlentherapie"},{"key":"10.1038\/labinvest.2010.186_bib31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bcp.2004.12.011","article-title":"Mechanism for the inhibition of transglutaminase 2 by cystamine","volume":"69","author":"Jeitner","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/labinvest.2010.186_bib32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00726-008-0211-x","article-title":"An overview of the first 50 years of transglutaminase research","volume":"36","author":"Beninati","year":"2009","journal-title":"Amino Acids"},{"key":"10.1038\/labinvest.2010.186_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-5521(03)00055-3","article-title":"A molecular warhead and its target: tissue transglutaminase and Celiac Sprue","volume":"10","author":"Schuppan","year":"2003","journal-title":"Chem Biol"},{"key":"10.1038\/labinvest.2010.186_bib34","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/gut.37.5.690","article-title":"Transglutaminases in Crohn's disease","volume":"37","author":"D'Argenio","year":"1995","journal-title":"Gut"},{"key":"10.1038\/labinvest.2010.186_bib35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1023\/A:1005680022573","article-title":"Serum transglutaminase correlates with endoscopic and histopathologic grading in patients with ulcerative colitis","volume":"46","author":"D'Argenio","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1038\/labinvest.2010.186_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/gut.34.1.75","article-title":"Factor XIIIA subunit and Crohn's disease","volume":"34","author":"Hudson","year":"1993","journal-title":"Gut"},{"key":"10.1038\/labinvest.2010.186_bib37","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.2741\/2030","article-title":"Transglutaminase 2 in inflammation","volume":"11","author":"Kim","year":"2006","journal-title":"Front Biosci"},{"key":"10.1038\/labinvest.2010.186_bib38","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1023\/A:1005541512152","article-title":"Recombinant factor XIII improves established experimental colitis in rats","volume":"45","author":"D'Argenio","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1038\/labinvest.2010.186_bib39","first-page":"534","article-title":"[Substitution of factor XIII concentrate in treatment refractory ulcerative colitis. A prospective pilot study]","volume":"89","author":"Lorenz","year":"1994","journal-title":"Med Klin (Munich)"},{"key":"10.1038\/labinvest.2010.186_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200315937","article-title":"Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis","volume":"111","author":"Sohn","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2010.186_bib41","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.4049\/jimmunol.180.4.2616","article-title":"Transglutaminase type II is involved in the pathogenesis of endotoxic shock","volume":"180","author":"Falasca","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2010.186_bib42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0167-4781(95)00088-X","article-title":"Transcription factors as targets for oxidative signalling during lymphocyte activation","volume":"1263","author":"Goldstone","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/labinvest.2010.186_bib43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cytogfr.2006.09.003","article-title":"Interleukin-6 trans-signaling in inflammatory bowel disease","volume":"17","author":"Mitsuyama","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1038\/labinvest.2010.186_bib44","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.4049\/jimmunol.171.6.3179","article-title":"Identification of tissue transglutaminase as a novel molecule involved in human CD8+ T cell transendothelial migration","volume":"171","author":"Mohan","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2010.186_bib45","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neurobiolaging.2005.04.001","article-title":"The protective effects of cystamine in the R6\/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase","volume":"27","author":"Bailey","year":"2006","journal-title":"Neurobiol Aging"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest2010186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2010186","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722024540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722024540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2010186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:48:47Z","timestamp":1758397727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722024540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0023683722024540"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2010.186","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2010.186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}